Nisa Investment Advisors
DNTH icon

Nisa Investment Advisors’s Dianthus Therapeutics DNTH Stock Holding History

Nisa Investment Advisors’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.2K Buy
634
+419
+195% +$24.3K ﹤0.01% 1642
2025
Q4 		$8.86K Buy
215
+165
+330% +$6.4K ﹤0.01% 2275
2025
Q3 		$1.97K Hold
50
– – ﹤0.01% 2624
2025
Q2 		$932 Sell
50
-40
-44% -$750 ﹤0.01% 2748
2025
Q1 		$1.63K Buy
90
+72
+400% +$1.59K ﹤0.01% 2521
2024
Q4 		$392 Sell
18
-55
-75% -$1.41K ﹤0.01% 2869
2024
Q3 		$2K Buy
+73
New +$2.03K ﹤0.01% 2400
2022
Q2 		– Sell
-500
Closed -$23K – 2401
2022
Q1 		$23K Buy
+500
New +$27.3K ﹤0.01% 2021
2021
Q4 		– Sell
-962
Closed -$112 – 2265
2021
Q3 		$112 Buy
+962
New +$112K ﹤0.01% 1646

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nisa Investment Advisors's DNTH Position: Q1 2026 in Review

Nisa Investment Advisors increased its Dianthus Therapeutics (DNTH) stake by 195% in Q1 2026, buying an estimated $24.3K and bringing the position to 634 shares worth $53.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1642.

Nisa Investment Advisors first reported a position in DNTH in Q3 2021 and has held it in 9 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Nisa Investment Advisors held 634 shares of Dianthus Therapeutics worth $53.2K as of Q1 2026.
  • Nisa Investment Advisors bought 419 Dianthus Therapeutics shares in Q1 2026, an estimated $24.3K.
  • Dianthus Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1642 holding.
  • Nisa Investment Advisors first reported a position in Dianthus Therapeutics in Q3 2021 and has held it in 9 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.